Aptar Pharma

Drug delivery systems provider Aptar Pharma, has announced that its Bidose nasal spray device was recently approved by the U.S. FDA for a breakthrough therapy in the field of depression. Read more

North America

A drug delivery systems provider will exhibit its respiratory portfolio at the Drug Delivery to the Lung (DDL) Conference 2018. Read more


Aptar Pharma, a provider of aerosol, injection and spray delivery systems said it has partnered with a “leading eye care company” to develop and launch a new eye drop product Read more


Aptar Pharma has provided the delivery system and regulatory support for Adapt Pharma’s Narcan, an FDA-approved nasally administered, needle-free medication that can stop or reverse the effects of an opioid overdose Read more